Cook Anne Marie

CIK 00013205594 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001320559

Recent Transactions

44 trades

Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2026-01-02+67,878→ 67,878 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2026-01-02+75,345→ 85,012 total
Tax Payment
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-12-17$15.36/sh−7,703→ 9,667 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Common Stock
2025-12-17+17,370→ 17,370 total
Award
Phathom Pharmaceuticals, Inc.$PHAT
Stock Option (Right to Buy)
2025-06-23+210,000→ 210,000 total
Award
Sage Therapeutics, Inc.
Common Stock
2024-08-05+13,500→ 28,543 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2024-08-05$8.96/sh−4,503→ 24,040 total
Award
Sage Therapeutics, Inc.
Common Stock
2024-02-13+11,250→ 25,181 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2024-02-13+22,500→ 22,500 total
Award
Sage Therapeutics, Inc.
Common Stock
2023-11-28+4,000→ 14,890 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2023-11-28$19.27/sh−1,174→ 13,716 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-02-13+19,000→ 19,000 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2023-02-03$44.16/sh−980→ 10,498 total
Award
Sage Therapeutics, Inc.
Common Stock
2023-02-03+2,850→ 11,478 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2022-02-11+15,200→ 15,200 total
Award
Sage Therapeutics, Inc.
Common Stock
2021-10-19+3,800→ 9,010 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2021-10-19$40.29/sh−1,116→ 7,894 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2021-06-15$58.80/sh−1,144→ 4,973 total
Award
Sage Therapeutics, Inc.
Common Stock
2021-06-15+4,000→ 6,117 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-02-10+19,000→ 19,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2020-04-28+9,450→ 9,450 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2020-02-12+20,000→ 20,000 total
Award
Sage Therapeutics, Inc.
Common Stock
2019-07-25+1,900→ 2,600 total
Tax Payment
Sage Therapeutics, Inc.
Common Stock
2019-07-25$161.38/sh−844→ 1,756 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2019-06-21+9,240→ 18,480 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2019-05-10$56.27/sh+700→ 700 total
Sale
Sage Therapeutics, Inc.
Common Stock
2019-05-10$166.14/sh−15,000→ 0 total
Exercise/Conversion
Sage Therapeutics, Inc.
Common Stock
2019-05-10$28.63/sh+15,000→ 15,000 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2019-05-10−15,000→ 15,000 total
Exercise/Conversion
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2019-05-10−700→ 109,300 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2019-02-13+19,000→ 19,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2018-12-07+9,240→ 9,240 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2018-04-02+31,500→ 31,500 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2017-02-06+56,000→ 56,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2016-12-08+10,000→ 40,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2016-02-08+40,000→ 40,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2015-09-16+110,000→ 110,000 total
Award
Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
2015-08-04+40,000→ 40,000 total
Award
Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
2015-04-01+40,000→ 40,000 total
Award
Aegerion Pharmaceuticals, Inc.
Restricted Stock Units
2015-04-01+10,000→ 10,000 total
Award
Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
2014-12-31+45,000→ 45,000 total
Award
Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
2013-04-01+20,000→ 20,000 total
Award
Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy)
2012-01-03+115,000→ 115,000 total
Award
VIACELL INC
Employee Stock Option (right to buy)
2005-09-21+75,000→ 75,000 total

Companies

Recent Filings

Address

C/O AEGERION PHARMACEUTICALS, INC. 101 MAIN STREET, SUITE 1850

CAMBRIDGE, MA, 02142

View on SEC.gov